SCOPUS 정보 검색 플랫폼

Volumn 48, Issue 11, 2009, Pages 1318-1329

Chronic PDE-5 inhibition in patients with erectile dysfunction. New treatment approach using once daily Tadalafil;Chronische PDE-5-Hemmung bei erektiler Dysfunktion. Neuer Therapieansatz mit täglicher Einmalgabe von Tadalafil

(3) Porst, H a Hell Momeni, K b Buttner H b

a Praxis für Urologie und Andrologie ^* (Germany)

b LILLY DEUTSCHLAND GMBH (Germany)

Author keywords

Endothelial dysfunction; Erectile dysfunction; PDE 5 inhibitors; Tadalafil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMYL NITRATE; CYCLIC GMP; DOXAZOSIN; GUANYLATE CYCLASE; NITRIC OXIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; TERAZOSIN; VARDENAFIL;

AREA UNDER THE CURVE; BACKACHE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPEPSIA; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; ERECTILE DYSFUNCTION; FACE ERYTHEMA; FOOD; FOOD DRUG INTERACTION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; LOW DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; MYALGIA; NOSE CONGESTION; PATIENT COMPLIANCE; PENIS ERECTION; REVIEW; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM; VASODILATATION;

BIOLOGICAL AVAILABILITY; CARBOLINES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HALF-LIFE; HUMANS; IMPOTENCE, VASCULOGENIC; LONG-TERM CARE; MALE; METABOLIC CLEARANCE RATE; PATIENT SATISFACTION; PHOSPHODIESTERASE INHIBITORS; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70949087930 PISSN: 03402592 EISSN: None Source Type: Journal
DOI: 10.1007/s00120-009-2089-y Document Type: Review

Times cited : (11)

References (61)

1
- 0028036149
- 8254833 1:STN:280:DyaK2c%2Fns1Ghtg%3D%3D
- Feldman 1994 J Urol 151 54 8254833 1:STN:280:DyaK2c%2Fns1Ghtg%3D%3D
- (1994) J Urol , vol.151 , pp. 54
- Feldman¹

2
- 84889309114
- Porst H, Buvat J (eds) Standard practice in sexual medicine. Blackwell Publishing, London
- Porst HU, Sharlip H (2006) History and epidemiology of male sexual dysfunction; In: Porst H, Buvat J (eds) Standard practice in sexual medicine. Blackwell Publishing, London, pp 43-48
- (2006) History and Epidemiology of Male Sexual Dysfunction , pp. 43-48
- Porst, H.U.¹ Sharlip, H.²

3
- 0036097281
- Quality of life and erectile dysfunction
- DOI 10.1016/S0090-4295(02)01606-0, PII S0090429502016060
- Althof 2002 Urology 59 803 10.1016/S0090-4295(02)01606-0 12031357 (Pubitemid 34522164)
- (2002) Urology , vol.59 , Issue.6 , pp. 803-810
- Althof, S.E.¹

4
- 10744225276
- Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease
- DOI 10.1016/S0302-2838(03)00305-1
- Montorsi 2003 Eur Urol 44 360 10.1016/S0302-2838(03)00305-1 12932937 (Pubitemid 37051707)
- (2003) European Urology , vol.44 , Issue.3 , pp. 360-365
- Montorsi, F.¹ Briganti, A.² Salonia, A.³ Rigatti, P.⁴ Margonato, A.⁵ Macchi, A.⁶ Galli, S.⁷ Ravagnani, P.M.⁸ Montorsi, P.⁹ Heaton, J.P.W.¹⁰

5
- 33748311881
- Association between Erectile Dysfunction and Coronary Artery Disease: Matching the Right Target with the Right Test in the Right Patient
- DOI 10.1016/j.eururo.2006.07.015, PII S0302283806008505
- Montorsi 2006 Eur Urol 50 721 10.1016/j.eururo.2006.07.015 16901623 (Pubitemid 44332685)
- (2006) European Urology , vol.50 , Issue.4 , pp. 721-731
- Montorsi, P.¹ Ravagnani, P.M.² Galli, S.³ Salonia, A.⁴ Briganti, A.⁵ Werba, J.P.⁶ Montorsi, F.⁷

6
- 0034660235
- Erectile dysfunction
- DOI 10.1056/NEJM200006153422407
- Lue 2000 N Engl J Med 342 1802 10.1056/NEJM200006153422407 10853004 1:CAS:528:DC%2BD3cXksVequ7c%3D (Pubitemid 30390241)
- (2000) New England Journal of Medicine , vol.342 , Issue.24 , pp. 1802-1813
- Lue, T.F.¹

7
- 0033104344
- The prevalence and etiology of impotence in 101 male hypertensive outpatients
- DOI 10.1016/S0895-7061(98)00225-8, PII S0895706198002258
- Jensen 1999 Am J Hypertens 12 271 10.1016/S0895-7061(98)00225-8 10192229 1:STN:280:DyaK1M3gs1CntQ%3D%3D (Pubitemid 29147352)
- (1999) American Journal of Hypertension , vol.12 , Issue.3 , pp. 271-275
- Jensen, J.¹ Lendorf, A.² Stimpel, H.³ Frost, J.⁴ Ibsen, H.⁵ Rosenkilde, P.⁶

8
- 0036676711
- 10.2337/diacare.25.8.1458 12145250
- Bacon 2002 Diabetes Care 25 1458 10.2337/diacare.25.8.1458 12145250
- (2002) Diabetes Care , vol.25 , pp. 1458
- Bacon¹

9
- 29144533834
- Erectile dysfunction and subsequent cardiovascular disease
- DOI 10.1001/jama.294.23.2996
- Thompson 2005 JAMA 294 2996 10.1001/jama.294.23.2996 16414947 1:CAS:528:DC%2BD2MXhtleltLrK (Pubitemid 41817661)
- (2005) Journal of the American Medical Association , vol.294 , Issue.23 , pp. 2996-3002
- Thompson, I.M.¹ Tangen, C.M.² Goodman, P.J.³ Probstfield, J.L.⁴ Moinpour, C.M.⁵ Coltman, C.A.⁶

10
- 4143077203
- Screening for ischemic heart disease in patients with erectile dysfunction: Role of penile Doppler ultrasonography
- DOI 10.1016/j.urology.2004.03.016, PII S0090429504003334
- El-Sakka 2004 Urology 64 346 10.1016/j.urology.2004.03.016 15302492 (Pubitemid 39092468)
- (2004) Urology , vol.64 , Issue.2 , pp. 346-350
- El-Sakka, A.I.¹ Morsy, A.M.²

11
- 26844574414
- Subclinical coronary artery atherosclerosis in patients with erectile dysfunction
- DOI 10.1016/j.jacc.2005.06.068, PII S0735109705017213
- Chiurlia 2005 J Am Coll Cardiol 46 1503 10.1016/j.jacc.2005.06.068 16226175 (Pubitemid 41446186)
- (2005) Journal of the American College of Cardiology , vol.46 , Issue.8 , pp. 1503-1506
- Chiurlia, E.¹ D'Amico, R.² Ratti, C.³ Granata, A.R.⁴ Romagnoli, R.⁵ Modena, M.G.⁶

12
- 14744293882
- Endothelial dysfunction links erectile dysfunction to heart disease
- DOI 10.1111/j.1742-1241.2005.00453.x
- Kirby 2005 Int J Clin Pract 59 225 10.1111/j.1742-1241.2005.00453.x 15854201 1:STN:280:DC%2BD2M3itVGhug%3D%3D (Pubitemid 40331225)
- (2005) International Journal of Clinical Practice , vol.59 , Issue.2 , pp. 225-229
- Kirby, M.¹ Jackson, G.² Simonsen, U.³

13
- 33750913713
- Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease
- DOI 10.1093/eurheartj/ehl341
- Vlachopoulos 2006 Eur Heart J 27 2640 10.1093/eurheartj/ehl341 17056702 1:CAS:528:DC%2BD28XhtlCmtbjJ (Pubitemid 44729862)
- (2006) European Heart Journal , vol.27 , Issue.22 , pp. 2640-2648
- Vlachopoulos, C.¹ Aznaouridis, K.² Ioakeimidis, N.³ Rokkas, K.⁴ Vasiliadou, C.⁵ Alexopoulos, N.⁶ Stefanadi, E.⁷ Askitis, A.⁸ Stefanadis, C.⁹

14
- 0037752795
- Is erectile dysfunction the tip of the lceberg of a systemic vascular disorder?
- DOI 10.1016/S0302-2838(03)00307-5
- Montorsi 2003 Eur Urol 44 352 10.1016/S0302-2838(03)00307-5 12932935 (Pubitemid 37051705)
- (2003) European Urology , vol.44 , Issue.3 , pp. 352-354
- Montorsi, P.¹ Montorsi, F.² Schulman, C.C.³

15
- 20844463760
- Brachial artery vasodilator function and systemic inflammation in the framingham offspring study
- DOI 10.1161/01.CIR.0000148821.97162.5E
- Vita 2004 Circulation 110 3604 10.1161/01.CIR.0000148821.97162.5E 15569842 1:CAS:528:DC%2BD2MXhtVGntLw%3D (Pubitemid 39612578)
- (2004) Circulation , vol.110 , Issue.23 , pp. 3604-3609
- Vita, J.A.¹ Keaney Jr., J.F.² Larson, M.G.³ Keyes, M.J.⁴ Massaro, J.M.⁵ Lipinska, I.⁶ Lehman, B.T.⁷ Fan, S.⁸ Osypiuk, E.⁹ Wilson, P.W.F.¹⁰ Vasan, R.S.¹¹ Mitchell, G.F.¹² Benjamin, E.J.¹³

16
- 4444324584
- Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress
- DOI 10.1016/j.cardiores.2004.06.020, PII S0008636304002779
- Clapp 2004 Cardiovasc Res 64 172 10.1016/j.cardiores.2004.06.020 15364625 1:CAS:528:DC%2BD2cXnsFGlurw%3D (Pubitemid 39208934)
- (2004) Cardiovascular Research , vol.64 , Issue.1 , pp. 172-178
- Clapp, B.R.¹ Hingorani, A.D.² Kharbanda, R.K.³ Mohamed-Ali, V.⁴ Stephens, J.W.⁵ Vallance, P.⁶ MacAllister, R.J.⁷

17
- 0024559857
- Saenz 1989 N Engl J Med 320 1025
- (1989) N Engl J Med , vol.320 , pp. 1025
- Saenz¹

18
- 0025081992
- Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
- DOI 10.1016/0006-291X(90)92168-Y
- Ignarro 1990 Biochem Biophys Res Commun 170 843 10.1016/0006-291X(90) 92168-Y 2166511 1:CAS:528:DyaK3cXltFejsLY%3D (Pubitemid 20249496)
- (1990) Biochemical and Biophysical Research Communications , vol.170 , Issue.2 , pp. 843-850
- Ignarro, L.J.¹ Bush, P.A.² Buga, G.M.³ Wood, K.S.⁴ Fukuto, J.M.⁵ Rajfer, J.⁶

19
- 0034758378
- 10.1136/heart.85.3.342 11179281 1:STN:280:DC%2BD3M3msFarug%3D%3D
- Vallance 2001 Heart 85 342 10.1136/heart.85.3.342 11179281 1:STN:280:DC%2BD3M3msFarug%3D%3D
- (2001) Heart , vol.85 , pp. 342
- Vallance¹

20
- 33748686575
- Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
- DOI 10.1124/pr.58.3.5
- Bender 2006 Pharmacol Rev 58 488 10.1124/pr.58.3.5 16968949 1:CAS:528:DC%2BD28XhtVOhtLfI (Pubitemid 44394910)
- (2006) Pharmacological Reviews , vol.58 , Issue.3 , pp. 488-520
- Bender, A.T.¹ Beavo, J.A.²

21
- 27244459472
- Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors
- DOI 10.1167/iovs.05-0257
- Zhang 2005 Invest Ophthalmol Vis Sci 46 3060 10.1167/iovs.05-0257 16123402 (Pubitemid 44264288)
- (2005) Investigative Ophthalmology and Visual Science , vol.46 , Issue.9 , pp. 3060-3066
- Zhang, X.¹ Feng, Q.² Cote, R.H.³

22
- 70949104480
- Porst 2006 Eur Urol 50 1094
- (2006) Eur Urol , vol.50 , pp. 1094
- Porst¹

23
- 41349107245
- 10.1016/j.urology.2007.12.025 18387397
- McCullough 2008 Urology 71 686 10.1016/j.urology.2007.12.025 18387397
- (2008) Urology , vol.71 , pp. 686
- McCullough¹

24
- 0038353576
- Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial
- DOI 10.1016/S0090-4295(03)00359-5
- Porst 2003 Urology 62 121 10.1016/S0090-4295(03)00359-5 12837435 (Pubitemid 36802084)
- (2003) Urology , vol.62 , Issue.1 , pp. 121-126
- Porst, H.¹ Padma-Nathan, H.² Giuliano, F.³ Anglin, G.⁴ Varanese, L.⁵ Rosen, R.⁶

25
- 33644925565
- Tadalafil pharmacokinetics in healthy subjects
- DOI 10.1111/j.1365-2125.2005.02553.x
- Forgue 2006 Br J Clin Pharmacol 61 280 10.1111/j.1365-2125.2005.02553.x 16487221 1:CAS:528:DC%2BD28XislKhsLc%3D (Pubitemid 43382627)
- (2006) British Journal of Clinical Pharmacology , vol.61 , Issue.3 , pp. 280-288
- Forgue, S.T.¹ Patterson, B.E.² Bedding, A.W.³ Payne, C.D.⁴ Phillips, D.L.⁵ Wrishko, R.E.⁶ Mitchell, M.I.⁷

26
- 0036706532
- Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery
- DOI 10.1016/S0090-4295(02)01687-4, PII S0090429502016795
- Carson 2002 Urology 60 12 10.1016/S0090-4295(02)01687-4 12414330 (Pubitemid 36153109)
- (2002) Urology , vol.60 , Issue.SUPPL. 1 , pp. 12-18
- Robinson, J.W.¹ Donnelly, B.J.² Saliken, J.C.³ Weber, B.A.⁴ Ernst, S.⁵ Rewcastle, J.C.⁶

27
- 0032516296
- Oral sildenafil in the treatment of erectile dysfunction
- DOI 10.1056/NEJM199805143382001
- Goldstein 1998 N Engl J Med 338 1397 10.1056/NEJM199805143382001 9580646 1:CAS:528:DyaK1cXjsVWitbs%3D (Pubitemid 28221980)
- (1998) New England Journal of Medicine , vol.338 , Issue.20 , pp. 1397-1404
- Goldstein, I.¹ Lue, T.F.² Padma-nathan, H.³ Rosen, R.C.⁴ Steers, W.D.⁵ Wicker, P.A.⁶

28
- 0034868820
- The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at-home clinical trial
- DOI 10.1038/sj.ijir.3900713
- Porst 2001 Int J Impot Res 13 192 10.1038/sj.ijir.3900713 11494074 1:STN:280:DC%2BD3Mvks1egtw%3D%3D (Pubitemid 32743600)
- (2001) International Journal of Impotence Research , vol.13 , Issue.4 , pp. 192-199
- Porst, H.¹ Rosen, R.² Padma-Nathan, H.³ Goldstein, I.⁴ Giuliano, F.⁵ Ulbrich, E.⁶

29
- 0036783940
- 10.1016/S0022-5347(05)64442-4 12352386 1:CAS:528:DC%2BD38Xot1Sqsbw%3D
- Brock 2002 J Urol 168 1332 10.1016/S0022-5347(05)64442-4 12352386 1:CAS:528:DC%2BD38Xot1Sqsbw%3D
- (2002) J Urol , vol.168 , pp. 1332
- Brock¹

30
- 33750484649
- Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: A randomized, double-blind, pooled crossover study
- DOI 10.1111/j.1743-6109.2006.00310.x
- Rubio-Aurioles 2006 J Sex Med 3 1037 10.1111/j.1743-6109.2006.00310.x 17100937 1:CAS:528:DC%2BD28XhtlWmsLvI (Pubitemid 44644716)
- (2006) Journal of Sexual Medicine , vol.3 , Issue.6 , pp. 1037-1049
- Rubio-aurioles, E.¹ Porst, H.² Eardley, I.³ Goldstein, I.⁴

31
- 33747694337
- Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors
- DOI 10.1111/j.1743-6109.2006.00297.x
- Tolrà 2006 J Sex Med 3 901 10.1111/j.1743-6109.2006.00297.x 16942534 1:CAS:528:DC%2BD28XhtVOns77F (Pubitemid 44269546)
- (2006) Journal of Sexual Medicine , vol.3 , Issue.5 , pp. 901-909
- Tolra, J.R.¹ Campana, J.M.C.² Ciutat, L.F.³ Miranda, E.F.⁴

32
- 33644994319
- Rodríguez 2006 Actas Urol Esp 30 67
- (2006) Actas Urol Esp , vol.30 , pp. 67
- Rodríguez¹

33
- 28544444480
- An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy
- DOI 10.1111/j.1464-410X.2005.05892.x
- Eardley 2005 BJU Int 96 1323 10.1111/j.1464-410X.2005.05892.x 16287454 1:CAS:528:DC%2BD28XivVCjsw%3D%3D (Pubitemid 41743933)
- (2005) BJU International , vol.96 , Issue.9 , pp. 1323-1332
- Eardley, I.¹ Mirone, V.² Montorsi, F.³ Ralph, D.⁴ Kell, P.⁵ Warner, M.R.⁶ Zhao, Y.⁷ Beardsworth, A.⁸

34
- 33745282103
- Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, open-label, crossover study
- DOI 10.1111/j.1743-6109.2006.00261.x
- Dean 2006 J Sex Med 3 650 10.1111/j.1743-6109.2006.00261.x 16839321 1:CAS:528:DC%2BD28XnsVWitbY%3D (Pubitemid 43919019)
- (2006) Journal of Sexual Medicine , vol.3 , Issue.4 , pp. 650-661
- Dean, J.¹ Hackett, G.I.² Gentile, V.³ Pirozzi-Farina, F.⁴ Rosen, R.C.⁵ Zhao, Y.⁶ Warner, M.R.⁷ Beardsworth, A.⁸

35
- 70949085186
- Sommer 2004 Eur Urol Suppl 3 410
- (2004) Eur Urol Suppl , vol.3 , pp. 410
- Sommer¹

36
- 70949101134
- Porst 2004 Eur Urol 3 99
- (2004) Eur Urol , vol.3 , pp. 99
- Porst¹

37
- 1642341195
- A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil
- DOI 10.1016/j.eururo.2003.11.030, PII S030228380300647X
- von 2004 Eur Urol 45 499 10.1016/j.eururo.2003.11.030 1:CAS:528:DC%2BD2cXjtlKitrc%3D (Pubitemid 38376216)
- (2004) European Urology , vol.45 , Issue.4 , pp. 499-507
- Von Keitz, A.¹ Rajfer, J.² Segal, S.³ Murphy, A.⁴ Denne, J.⁵ Costigan, T.⁶ Lockhart, D.⁷ Beasley Jr., C.M.⁸ Emmick, J.T.⁹

38
- 29044435933
- Porst 2004 Eur Urol 3 408
- (2004) Eur Urol , vol.3 , pp. 408
- Porst¹

39
- 0345095481
- A Multicenter, Randomized, Double-Blind, Crossover Study of Patient Preference for Tadalafil 20 mg or Sildenafil Citrate 50 mg During Initiation of Treatment for Erectile Dysfunction
- DOI 10.1016/S0149-2918(03)80328-4
- Govier 2003 Clin Ther 25 2709 10.1016/S0149-2918(03)80328-4 14693299 1:CAS:528:DC%2BD2cXhtVygtw%3D%3D (Pubitemid 37510585)
- (2003) Clinical Therapeutics , vol.25 , Issue.11 , pp. 2709-2723
- Govier, F.¹ Potempa, A.-J.² Kaufman, J.³ Denne, J.⁴ Kovalenko, P.⁵ Ahuja, S.⁶

40
- 17944400551
- Switching Patients with Erectile Dysfunction from Sildenafil Citrate to Tadalafil: Results of a European Multicenter, Open-Label Study of Patient Preference
- DOI 10.1016/S0149-2918(03)80329-6
- Ströberg 2003 Clin Ther 25 2724 10.1016/S0149-2918(03)80329-6 14693300 (Pubitemid 37510586)
- (2003) Clinical Therapeutics , vol.25 , Issue.11 , pp. 2724-2737
- Stroberg, P.¹ Murphy, A.² Costigan, T.³

41
- 33645731017
- 10.1111/j.1743-6109.2005.00194.x 16409214 1:CAS:528:DC%2BD28XhslOisbY%3D
- Laties 2006 J Sex Med 3 12 10.1111/j.1743-6109.2005.00194.x 16409214 1:CAS:528:DC%2BD28XhslOisbY%3D
- (2006) J Sex Med , vol.3 , pp. 12
- Laties¹

42
- 0242552045
- Time Course of the Interaction between Tadalafil and Nitrates
- DOI 10.1016/j.jacc.2003.09.023
- Kloner 2003 J AM Coll Cardiol 42 1855 10.1016/j.jacc.2003.09.023 14642699 1:CAS:528:DC%2BD3sXpvVGjsbg%3D (Pubitemid 37433669)
- (2003) Journal of the American College of Cardiology , vol.42 , Issue.10 , pp. 1855-1860
- Kloner, R.A.¹ Hutter, A.M.² Emmick, J.T.³ Mitchell, M.I.⁴ Denne, J.⁵ Jackson, G.⁶

43
- 33745866247
- Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5 mg and 10 mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- DOI 10.1016/j.eururo.2006.02.052, PII S0302283806002880
- Porst 2006 Eur Urol 50 351 10.1016/j.eururo.2006.02.052 16766116 1:CAS:528:DC%2BD28XovFWlsLk%3D (Pubitemid 44038075)
- (2006) European Urology , vol.50 , Issue.2 , pp. 351-359
- Porst, H.¹ Giuliano, F.² Glina, S.³ Ralph, D.⁴ Casabe, A.R.⁵ Elion-Mboussa, A.⁶ Shen, W.⁷ Whitaker, J.S.⁸

44
- 10744231934
- Long-Term Safety and Tolerability of Tadalafil in the Treatment of Erectile Dysfunction
- DOI 10.1016/j.eururo.2003.11.010
- Montorsi 2004 Eur Urol 45 339 10.1016/j.eururo.2003.11.010 15036680 1:CAS:528:DC%2BD2cXisVWmur0%3D (Pubitemid 38221407)
- (2004) European Urology , vol.45 , Issue.3 , pp. 339-345
- Montorsi, F.¹ Verheyden, B.² Meuleman, E.³ Junemann, K.-P.⁴ Moncada, I.⁵ Valiquette, L.⁶ Casabe, A.⁷ Pacheco, C.⁸ Denne, J.⁹ Knight, J.¹⁰ Segal, S.¹¹ Watkins, V.S.¹²

45
- 33645744143
- 10.1111/j.1743-6109.2005.00197.x 16409221 1:CAS:528:DC%2BD28XhslOitr8%3D
- Vernet 2006 J Sex Med 3 84 10.1111/j.1743-6109.2005.00197.x 16409221 1:CAS:528:DC%2BD28XhslOitr8%3D
- (2006) J Sex Med , vol.3 , pp. 84
- Vernet¹

46
- 19744370637
- Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction
- DOI 10.1111/j.1743-6109.2005.20360.x
- McMahon 2005 J Sex Med 2 415 10.1111/j.1743-6109.2005.20360.x 16422874 1:CAS:528:DC%2BD2MXkslaltbo%3D (Pubitemid 40744383)
- (2005) Journal of Sexual Medicine , vol.2 , Issue.3 , pp. 415-427
- McMahon, C.¹ Kloner, R.A.² Hutter Jr., A.M.³ Porst, H.⁴

47
- 33847361439
- Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction
- DOI 10.1038/sj.ijir.3901490, PII 3901490
- Dunn 2007 Int J Impot Res 19 119 10.1038/sj.ijir.3901490 16738695 1:CAS:528:DC%2BD2sXit12rtL8%3D (Pubitemid 46340827)
- (2007) International Journal of Impotence Research , vol.19 , Issue.2 , pp. 119-123
- Dunn, M.E.¹ Althof, S.E.² Perelman, M.A.³

48
- 12344288164
- Chronic treatment with Tadalafil improves endothelial function in men with increased cardiovascular risk
- DOI 10.1016/j.eururo.2004.10.002, PII S0302283804005093
- Rosano 2005 Eur Urol 47 214 10.1016/j.eururo.2004.10.002 15661417 1:CAS:528:DC%2BD2MXhslyht70%3D (Pubitemid 40126979)
- (2005) European Urology , vol.47 , Issue.2 , pp. 214-222
- Rosano, G.M.C.¹ Aversa, A.² Vitale, C.³ Fabbri, A.⁴ Fini, M.⁵ Spera, G.⁶

49
- 0029117715
- 10.1136/hrt.74.3.247 7547018 1:STN:280:DyaK28%2Fks1ektg%3D%3D
- Sorensen 1995 Br Heart J 74 247 10.1136/hrt.74.3.247 7547018 1:STN:280:DyaK28%2Fks1ektg%3D%3D
- (1995) Br Heart J , vol.74 , pp. 247
- Sorensen¹

50
- 33748291505
- Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction
- DOI 10.1038/sj.ijir.3901465, PII 3901465
- Foresta 2006 Int J Impot Res 18 484 10.1038/sj.ijir.3901465 16541115 1:CAS:528:DC%2BD28XptVCls7g%3D (Pubitemid 44330301)
- (2006) International Journal of Impotence Research , vol.18 , Issue.5 , pp. 484-488
- Foresta, C.¹ Ferlin, A.² De Toni, L.³ Lana, A.⁴ Vinanzi, C.⁵ Galan, A.⁶ Caretta, N.⁷

51
- 7944223539
- Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis?
- DOI 10.1007/s00109-004-0580-x
- Dimmeler 2004 J Mol Med 82 671 10.1007/s00109-004-0580-x 15322703 (Pubitemid 39468491)
- (2004) Journal of Molecular Medicine , vol.82 , Issue.10 , pp. 671-677
- Dimmeler, S.¹ Zeiher, A.M.²

52
- 33846059081
- The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size
- DOI 10.1038/sj.ijir.3901497, PII 3901497
- Sesti 2007 Int J Impot Res 19 55 10.1038/sj.ijir.3901497 16858368 1:CAS:528:DC%2BD2sXhsFymsg%3D%3D (Pubitemid 46067349)
- (2007) International Journal of Impotence Research , vol.19 , Issue.1 , pp. 55-61
- Sesti, C.¹ Florio, V.² Johnson, E.G.³ Kloner, R.A.⁴

53
- 33847367689
- The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems
- DOI 10.1038/sj.ijir.3901491, PII 3901491
- Schwarz 2007 Int J Impot Res 19 139 10.1038/sj.ijir.3901491 16761012 1:CAS:528:DC%2BD2sXit12rtLw%3D (Pubitemid 46340828)
- (2007) International Journal of Impotence Research , vol.19 , Issue.2 , pp. 139-148
- Schwarz, E.R.¹ Kapur, V.² Rodriguez, J.³ Rastogi, S.⁴ Rosanio, S.⁵

54
- 15844381929
- Efficacy and safety daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil
- DOI 10.1111/j.1743-6109.04042.x
- McMahon 2004 J Sex Med 1 292 10.1111/j.1743-6109.04042.x 16422959 1:CAS:528:DC%2BD2MXjtFemt70%3D (Pubitemid 40424638)
- (2004) Journal of Sexual Medicine , vol.1 , Issue.3 , pp. 292-300
- McMahon, C.¹

55
- 33846073648
- Tadalafil dosed once a day in men with erectile dysfunction: A randomized, double-blind, placebo-controlled study in the US
- DOI 10.1038/sj.ijir.3901496, PII 3901496
- Rajfer 2007 Int J Impot Res 19 95 10.1038/sj.ijir.3901496 16871272 1:CAS:528:DC%2BD2sXhsFynuw%3D%3D (Pubitemid 46067355)
- (2007) International Journal of Impotence Research , vol.19 , Issue.1 , pp. 95-103
- Rajfer, J.¹ Aliotta, P.J.² Steidle, C.P.³ Fitch III, W.P.⁴ Zhao, Y.⁵ Yu, A.⁶

56
- 33847362727
- Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: A pilot study
- DOI 10.1038/sj.ijir.3901513, PII 3901513
- Aversa 2007 Int J Impot Res 19 200 10.1038/sj.ijir.3901513 16943794 1:CAS:528:DC%2BD2sXit12rtbw%3D (Pubitemid 46340840)
- (2007) International Journal of Impotence Research , vol.19 , Issue.2 , pp. 200-207
- Aversa, A.¹ Greco, E.² Bruzziches, R.³ Pili, M.⁴ Rosano, G.⁵ Spera, G.⁶

57
- 51349111890
- 10.1111/j.1743-6109.2008.00935.x 18557812 1:CAS:528:DC%2BD1cXhtFylsr%2FL
- Porst 2008 J Sex Med 5 2160 10.1111/j.1743-6109.2008.00935.x 18557812 1:CAS:528:DC%2BD1cXhtFylsr%2FL
- (2008) J Sex Med , vol.5 , pp. 2160
- Porst¹

58
- 44149125039
- 10.1016/j.eururo.2008.03.056 18395326
- Zumbé 2008 Eur Urol 54 204 10.1016/j.eururo.2008.03.056 18395326
- (2008) Eur Urol , vol.54 , pp. 204
- Zumbé¹

59
- 15844395323
- Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events
- DOI 10.1111/j.1743-6109.2004.04024.x
- Jackson 2004 J Sex Med 1 161 10.1111/j.1743-6109.2004.04024.x 16422970 1:CAS:528:DC%2BD2MXjtFemt7c%3D (Pubitemid 40424649)
- (2004) Journal of Sexual Medicine , vol.1 , Issue.2 , pp. 161-167
- Jackson, G.¹ Kloner, R.A.² Costigan, T.M.³ Warner, M.R.⁴ Emmick, J.T.⁵

60
- 39749105966
- 10.1111/j.1464-5491.2007.02338.x 1:CAS:528:DC%2BD1cXktVajs78%3D
- Hatzichristou 2007 Diabet Med 25 138 10.1111/j.1464-5491.2007.02338.x 1:CAS:528:DC%2BD1cXktVajs78%3D
- (2007) Diabet Med , vol.25 , pp. 138
- Hatzichristou¹

61
- 33746154470
- Comparison of phosphodiesterase type 5 (PDE5) inhibitors
- DOI 10.1111/j.1742-1241.2006.01049.x
- Wright 2006 Int J Clin Pract 60 967 10.1111/j.1742-1241.2006.01049.x 16780568 1:CAS:528:DC%2BD28XpvVemsb0%3D (Pubitemid 44082288)
- (2006) International Journal of Clinical Practice , vol.60 , Issue.8 , pp. 967-975
- Wright, P.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.